Navigation Links
Detecting tumors faster
Date:6/7/2010

This release is available in German.

Early detection is the key to the successful treatment of cancer. But not every lump turns out to be a malignant tumor. To find out whether cancerous cells are present, doctors usually conduct a biopsy and examine the removed tissue under the microscope. This process is not only very stressful for the patient but also highly time consuming. Research scientists at the Fraunhofer Institute for Photonic Microsystems IPMS in Dresden are aiming to considerably speed up cancer diagnosis. They have developed a microscope head with a diameter of just eight millimeters which can optically resolve and magnify tissue cells measuring just 10 to 20 micrometers. Fitted in the tip of an endoscope it will be used for in vivo cancer diagnosis, inserted in the body as in a minimally invasive surgical operation. The scientists envision that the MEMS (micro-electro-mechanical system) microscope head will eliminate the need for biopsies. Diagnosis in real time would enable doctors to decide on the necessary course of treatment more quickly.

Microscopic image recorders that can be used on endoscopes have not been available up to now. We have developed the first laser-based sensor for this purpose, says Dr. Michael Scholles, business unit manager at the IPMS. In classic endoscopy using macroscopic imaging, the job can be done by CCD or CMOS image sensors, as used in digital cameras and cellphones. For endomicroscopy, however, MEMS-based image sensors are highly advantageous because they can magnify even the smallest object fields, such as cells, without the need for a large lens. We have combined the sensor with a microscanner mirror to achieve the required resolution of 10 micrometers and can therefore massively magnify the tiniest structures.

But how does the system function? The laser itself is located in the operating theater. The laser light is conducted via a transmitting fiber to the microscanner mirror fitted in the tip of the endoscope. This deflects the laser beam and illuminates the suspicious tissue specifically. A glass-fiber bundle in the tip of the endoscope transmits the reflected light to the external sensor, which thus receives a signal containing the image information. A detector precisely measures the position of the scanner mirror, indicating which area of the scene is being illuminated at the specific point in time. A two-dimensional image can thus be completely reconstructed by combining the position and image sensor signals.

An important aspect of the development was to produce a suitable microassembly for the endoscope head. Here we faced the challenge of making the complete system suitable for installation in the endoscope, and we managed to do it. In future our microscope head will be produced in large quantities in an automated process for subsequent installation in endoscopes, explains Scholles. The expert envisages a wide range of applications for the system: It could be used not only in medical and biological microscopy but also in technical endoscopy, for instance to examine cavities in buildings or to inspect the insides of engines and turbines. The microscope head has already been produced as a demonstrator and can be seen at the Optatec trade show in Frankfurt from June 15 to 18 (Hall 3, Stand D50).


'/>"/>

Contact: Michael Scholles
michael.scholles@ipms.fraunhofer.de
49-351-882-3201
Fraunhofer-Gesellschaft
Source:Eurekalert  

Related medicine news :

1. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
2. Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery
3. Researchers discover novel method for detecting MIRCERA
4. Drug that helps metastatic colon cancer of no benefit in less advanced tumors
5. Black Men at Greater Risk of Aggressive Prostate Tumors: Study
6. Childhood Brain Tumors May Respond to Measles Virus
7. A new cancer vaccine starves tumors of blood
8. ASCO data highlight novel anti-cancer approach that exposes tumors to immune attack
9. Drug now used to treat erectile dysfuncton may enhance delivery of herceptin to certain brain tumors
10. Obesity Behind Rise of Phantom Brain Tumors in Children
11. Molecular discovery points to new therapies for brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Detecting tumors faster
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/24/2017)... MN (PRWEB) , ... February 24, 2017 , ... ... of its newly designed TaskMate Go. Core benefits and advantages built into the ... and a stylish, functional look and feel. Ability to gain the benefits embedded ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald ... officially announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, ... (LUCOM), beginning April 10. Dr. Bell comes to Liberty from the Ohio University ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... February 24, 2017 , ... Indiana Fiber Network (IFN) President ... later this year. Dyer started as the Chairman of the Management Committee when ... of the corporation including the recruitment of investor/owners and development of the business plan. ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 23, 2017  Directors from Pharma To Market Pty Ltd and ... forces, resulting in the founding of Pharma To Market Pte Ltd, ... Market are pleased to announce their expansion into Asia ... Singapore . The company are delighted to appoint Joelle ... Singapore based entity. Joelle brings with her ...
(Date:2/24/2017)... 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology drug ... has acquired exclusive worldwide rights to develop, manufacture ... inhibitor targeting hematological and solid tumors. ... and 2 clinical trials of Abexinostat in US, ... already been completed, demonstrating that Abexinostat is clinically ...
(Date:2/23/2017)... Südkorea, 23. Februar 2017 LG Innotek hat ... vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls der ... im Bereich zwischen 200 und 280 nm und eignet sich ... indem es ihre DNA zerstört. Das Produkt von LG ... ...
Breaking Medicine Technology: